Tirzepatide for Metabolic Dysfunction–Associated Steatohepatitis With Liver Fibrosis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Tirzepatide for Metabolic Dysfunction-Associated Steatohepatitis with Liver Fibrosis
N. Engl. J. Med 2024 Jun 08;[EPub Ahead of Print], R Loomba, ML Hartman, EJ Lawitz, R Vuppalanchi, J Boursier, E Bugianesi, M Yoneda, C Behling, OW Cummings, Y Tang, B Brouwers, DA Robins, A Nikooie, MC Bunck, A Haupt, AJ SanyalFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.